Weekly Recap | SKB BIO -9.45%, consensus target above spotWeekly Review·Nov 21, 2026 at 05:53 AM06990-5.59%
Weekly Recap | BEONE MEDICINES -7.46%, most brokers rate it buyWeekly Review·Nov 21, 2026 at 05:45 AM06160-4.86%
Weekly Recap | HANSOH PHARMA -9.32%, consensus target above spotWeekly Review·Nov 21, 2026 at 05:39 AM03692-5.18%
Weekly Recap | WUXI BIO -12.37%, most brokers rate it buyWeekly Review·Nov 21, 2026 at 05:25 AM02269-6.57%
Weekly Recap | WUXI APPTEC -4.22%, consensus target above spotWeekly Review·Nov 21, 2026 at 05:24 AM02359-3.61%
Weekly Recap | INNOVENT BIO -4.53%, most brokers rate it buyWeekly Review·Nov 21, 2026 at 05:14 AM01801-6.26%
Weekly Recap | GENSCRIPT BIO -8.92%, pullback outpacing the Hang Seng IndexWeekly Review·Nov 21, 2026 at 05:13 AM01548-7.96%
Weekly Recap | CSPC PHARMA -2.22%, most brokers rate it buyWeekly Review·Nov 21, 2026 at 05:07 AM01093-4.58%
Weekly Recap | SBP GROUP -7.35%, consensus target above spotWeekly Review·Nov 21, 2026 at 05:03 AM01177-4.85%
CSPC Pharmaceutical Group Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For Next YearSimplywall·Nov 20, 2026 at 10:04 PM01093-4.58%
AIâs billions and slick pledges heap pressure on pharma veteransBusinesstimes News·Nov 20, 2026 at 11:58 AMABBV+0.94%MRK+0.69%
WuXi AppTec Expects 2026 Chemistry Revenue of RMB 52.8 Billion-53.5 BillionPUBT·Nov 20, 2026 at 11:06 AM02359-3.61%603259-2.49%
WuXi AppTec Presents Research Platforms Supporting Integrated CRDMO ModelPUBT·Nov 20, 2026 at 11:05 AM02359-3.61%603259-2.49%
China Accepts Hansoh Pharmaceutical's Socrodeucitinib Application for Psoriasis TreatmentPUBT·Nov 20, 2026 at 10:31 AM03692-5.18%
HSBC Research Raises INNOVENT BIO TP to HKD133 as Johnson & Johnson Acquires Overseas Pipeline Partner OllinAASTOCKS News·Nov 20, 2026 at 09:25 AMJNJ+1.25%01801-6.26%